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A. Chaudhuri*
Bedford Hospital NHS Trust, Bedfordshire Vascular Unit, Kempston Road, Bedford MK42 9DJ, United KingdomAll vascular surgeons/radiologists are aware of the higher rate
and the implied costs of re-intervention after EVAR1: with
peripheral angioplasty, for instance, given that these are smaller
amounts often mean that these costs are swept under the carpet.
With EVAR and the associated higher costs of both procedure and
device, this becomes a signiﬁcant issue. Furthermore, all is ﬁne
when things are going well, but it is of course in the nature of
medicine for things to get complicated, particularly in this group of
patients who by default come with a host of co-morbidities; the
real issue is then with getting problems ﬁxed with minimal
disruption, i.e. an endovascular problem should ideally have an
endovascular solution. This is especially so with the authors
indicating a high mortality with open conversions, indicated in
a sense in their own cohort with a V-POSSUM score exceeding 11%.
There are several points to examine: ﬁrstly, the premise of the
paper itself. The authors present salvage AMI-redoEVAR for mostly
type I or type III endoleaks, and no one would debate the issue with
the need to deal with these and an increasing sac, though, as
referenced, even endotension has been treated as such. Importantly
this has also shown up shortcomings with older devices, and
certainly if the fabric in one Vanguard device disintegrated, how
many more are there waiting for the same to happen?
Secondly, follow-up. In the UK repeated outpatient follow-up
post-EVAR simply does not occur; this would likely upset the
balance in new-to-follow-up ratios, a criterion that is closely
performance managed. Yes, pulse examination can pick out
reduction in pulses, but reliable duplex examination can interro-
gate the ﬂow aspects in any case. I understand this has now been
modiﬁed. The ESVS guidelines for EVAR surveillance would be
a useful reference in this regard.2
Thirdly, access still remains an issue even the second time
around as indicated by the one failure, even though the authorsDOI of original article: 10.1016/j.ejvs.2012.07.009.
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now available, but following on frommy own correspondence with
Cook regarding my own patients, the turnover time for these is
about 8 weeks. AMI conversionwith/without femorofemoral (if the
contralateral limb is asymptomatically occluded)3 crossover
provides a simple and effective solution to the problems with
endoleaks and sac expansion as presented.
The future step in addressing top end migration, with a view to
reducing type Ia endoleaks, may well be to look at primary endo-
stapling/endoﬁxation using, for instance, the HeliFX Aortic
Securement System (Aptus Endosystems, Sunnyvale, CA,USA)
particularly for short/conical necks. A large trial/cohort study in this
context may well have a bearing on altering device IFUs related to
neck morphology.4
The authors provide real-life endovascular solutions, including
a clear report of the complications that still occur, that are easily
applicable in all centres undertaking EVAR. The next thing to see is
how much all this costs, ﬁnancially (given that an AMI conversion
would have pretty much doubled endograft cost per aneurysm)
and otherwise, especially if older devices start declaring their
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